• 1
    Oppenheim HZ. Dermatomyostitis. Berl klin Wochenschrift. 1899: 805807.
  • 2
    Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol. 1996;14:373379.
  • 3
    Taylor AJ, Wortham DC, Burge JR, et al. The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol. 1993;16: 802808.
  • 4
    Bohan A, Peter JB, Bowman RL, et al. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56:255286.
  • 5
    Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology (Oxford). 2006;45(suppl 4):iv18iv21.
  • 6
    Danko K, Ponyi A, Constantin T. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features. Medicine (Baltimore). 2004;83:3542.
  • 7
    Hochberg MC, Feldman D, Stevens MB. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum. 1986;15:168178.
  • 8
    Denbow CE, Lie JT, Tancredi RG, et al. Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum. 1979;22:10881092.
  • 9
    Benenbassat J, Gefel D, Larholt K. Progognostic factors in polymyositis/dermatomyosits. Arthritis Rheum. 1985;28:249255.
  • 10
    Kehoe RF, Robert B, Carl T. Cardiac conduction defects in polymyositis. Ann Intern Med. 1981;94:4143.
  • 11
    Stern R, Godbold JH, Chess Q, et al. ECG abnormalities in polymyositis. Arch Intern Med. 1984;144:21852189.
  • 12
    Haupt HM, Hutchins GM. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol. 1982;50:9981006.
  • 13
    Wilhelmina MHB, Behan Po, Gairns IJ. Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins. Br Heart J. 1987;57:176180.
  • 14
    Byrnes TJ, Baethge BA, Wolf RE. Noninvasive cardiovascular studies in patients with inflammatory myopathy. Angiology. 1991; 42:843848.
  • 15
    Gottdiener JS, Sherber HS, Hawley RJ, et al. Cardiac manifestations in polymyositis. Am J Cardiol. 1978,41:11411149.
  • 16
    Allanore Y, Vignaux O, Arnaud L, et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis. 2006;65:249252.
  • 17
    Buchpiguel CA, Roizemblatt S, Pastor EH, et al. Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: clinical implications. Eur J Nucl Med. 1996;23:199203.
  • 18
    Agrawal CS, Behari M, Shrivastava S, et al. The heart in polymyositis-dermatomyositis. J Neurol. 1989;236:249250.
  • 19
    Strongwater SL, Annesley T, Schnitzer TJ. Myocardial involvement in polymyositis. J Rheumatol. 1983;10:459463.
  • 20
    Plazak W, Kopeec G, Tomkiewica-Pajak L. Heart structure and function in patients with generalized autoimmune diseases: echocardiography with tissue Doppler study. Acta Cardiol. 2011; 66:159165.
  • 21
    Hebert CA, Byrnes TJ, Baethge BA, et al. Exercise limitation in patients with polymyositis. Chest. 1990;98:352357.
  • 22
    Askari AD. Inflammatory disorders of muscle. Cardiac abnormalities. Clin Rheum Dis. 1984;10:131149.
  • 23
    Vidya SL, Sue L, Peter B, et al. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis. 2010;13:132137.
  • 24
    Tisseverastinghe A, Bernatsky S, Christian AP. Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol. 2009;36:19431946.
  • 25
    Oka M, Raasakka T. Cardiac involvement in polymyositis. Scand J Rheumatol. 1978;7:203208.
  • 26
    Vander PJ, Hengstman GJ, LaaK T, et al. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry. 2004;75:136139.
  • 27
    Englund P, Nennesmo I, Klareskog L, et al. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum. 2002;46:10441055.
  • 28
    Kiely PD, Bruckner FE, Nisbet JA, et al. Serum skeletal troponin I in inflammatory muscle disease: relation to creatione kinase, CKMB and cardiac troponin. Ann Rheum Dis. 2000;59: 750751.
  • 29
    Rasmussen LH, Madsen HN, Ladefoged SD. Creatine phosphokinase MB and lactate dehydrogenase isoenzyme 1 in polymyositis. Scand J Rheumatol. 1985;14:427430.
  • 30
    Petra E, Angelika L, Jurgen F, et al. Cardiac troponin and b-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clinica Chimica Acta. 2001;306:2733.
  • 31
    Touma Z, Arayssi T, Kibbi L, et al. Successful treatment of cardiac involvement in dermatomyositis with rituximab. Joint Bone Spine. 2008;75:334337.
  • 32
    Afzal A, RSD H, Philbin EF. Heart transplant for dilated cardiomyopathy associated with polymyositis. Heart. 1999; 82:e4.
  • 33
    Corinne F, Sumeet A, Way MW, et al. Clinical observations on the significance of raised cardiac troponin-T in patients with myositis of varying etiologies seen in rheumatology practice. Clin Rheumatol. 2010;29:11071111.
  • 34
    Na S, Kim SM, Sunwoo N. Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J Korean Med Sci. 2009;24: 715721.
  • 35
    Sharratt GP, Danta G, Carson PH. Cardiac abnormality in polymyositis. Ann Rheum Dis. 1977;36:575578.